Yubai Zhou

Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma

Ting-zhen Guo, Hongtao Ma, Yubai Zhou, 2019, PeerJ.

Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma

Hongtao Ma, Yubai Zhou, Cheng Yue, 2019, PeerJ.

Development of a novel embryonic germline gene-related prognostic model of lung adenocarcinoma

Yubai Zhou, Ke Xu, Linjun Liu, 2021, PeerJ.

The Synthesis and Initial Evaluation of MerTK Targeted PET Agents

Zibo Li, Xiao-dong Wang, Ransheng Ding, 2022, Molecules.

UNC5293, a potent, orally available and highly MERTK-selective inhibitor.

S. Frye, Xiaodong Wang, H. Earp, 2021, European journal of medicinal chemistry.

LINC01117 inhibits invasion and migration of lung adenocarcinoma through influencing EMT process

Yubai Zhou, Licheng Du, K. Xu, 2023, bioRxiv.

Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions.

K. Pearce, Huanchen Wang, M. Chakraborty, 2022, Journal of medicinal chemistry.

Overexpression of Bruton Tyrosine Kinase Inhibits the Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer Cells

Yubai Zhou, Licheng Du, Ke Xu, 2023, Analytical cellular pathology.